All Stories

  1. Parainfluenza Fusion Peptide Promotes Membrane Fusion by Assembling into Oligomeric Porelike Structures
  2. The antimetastatic breast cancer activity of the viral protein‐derived peptide vCPP2319 as revealed by cellular biomechanics
  3. Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
  4. Exosomes and Brain Metastases: A Review on Their Role and Potential Applications
  5. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
  6. Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules
  7. Penetrating the Blood-Brain Barrier with New Peptide–Porphyrin Conjugates Having anti-HIV Activity
  8. Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
  9. Integrative Human Biochemistry
  10. Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein
  11. Effects of Diabetes on Microcirculation and Leukostasis in Retinal and Non-Ocular Tissues: Implications for Diabetic Retinopathy
  12. The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization
  13. DPepH3, an Improved Peptide Shuttle for Receptor-independent Transport Across the Blood-Brain Barrier
  14. Antifungal and anti-biofilm activity of designed derivatives from kyotorphin
  15. Can citation metrics predict the true impact of scientific papers?
  16. Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
  17. Pharmaceutical Innovations: The Grand Challenges Ahead
  18. Enfuvirtide-Protoporphyrin IX Dual-Loaded Liposomes: In Vitro Evidence of Synergy against HIV-1 Entry into Cells
  19. Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models
  20. Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix–Loop–Helix Peptides with Cell Penetrating and Tumor Suppressor Properties
  21. Structural determinants conferring unusual long life in human serum to rattlesnake‐derived antimicrobial peptide Ctn[15‐34]
  22. Optical coherence tomography angiography study of the retinal vascular plexuses in type 1 diabetes without retinopathy
  23. Synthesis and Characterization of Peptide–Chitosan Conjugates (PepChis) with Lipid Bilayer Affinity and Antibacterial Activity
  24. A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography
  25. The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms
  26. Bacteriocins as Anticancer Peptides: A Biophysical Approach
  27. Fast NMR method to probe solvent accessibility and disordered regions in proteins
  28. Plant defensin PvD1 modulates the membrane composition of breast tumour-derived exosomes
  29. Designing of Artificial Peptides for an Improved Antiviral Activity
  30. Structure–Stability–Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles
  31. Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane
  32. Biologically active peptides linked to antibody fragments
  33. Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15–34), antimicrobial peptides from rattlesnake venom
  34. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood–Brain Barrier Model
  35. Neuropeptide Kyotorphin Impacts on Lipopolysaccharide-Induced Glucocorticoid-Mediated Inflammatory Response. A Molecular Link to Nociception, Neuroprotection, and Anti-Inflammatory Action
  36. New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins
  37. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance
  38. Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX
  39. Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood–Brain Barrier through a Receptor-Free Mechanism
  40. Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides
  41. Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives
  42. siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model
  43. Challenging metastatic breast cancer with the natural defensinPvD1
  44. Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates
  45. In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence
  46. Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles
  47. Bacterial Biofilms in Diabetic Foot Ulcers: Potential Alternative Therapeutics
  48. Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors
  49. Fusing simulation and experiment: The effect of mutations on the structure and activity of the influenza fusion peptide
  50. Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation
  51. Structural Studies of a Lipid-Binding Peptide from Tunicate Hemocytes with Anti-Biofilm Activity
  52. A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity
  53. Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model
  54. Anticancer Peptides: Prospective Innovation in Cancer Therapy
  55. Antibody Approaches To Treat Brain Diseases
  56. Improvement of the pharmacological properties of amidated kyotorphin by means of iodination
  57. Dps fromDeinococcus radiodurans: oligomeric forms of Dps1 with distinct cellular functions and Dps2 involved in metal storage
  58. The anti-inflammatory action of the analgesic kyotorphin neuropeptide derivatives: insights of a lipid-mediated mechanism
  59. Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets
  60. Effects of singlet oxygen generated by a broad-spectrum viral fusion inhibitor on membrane nanoarchitecture
  61. Rethinking the capsid proteins of enveloped viruses: multifunctionality from genome packaging to genome transfection
  62. Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides
  63. Shifting gear in antimicrobial and anticancer peptides biophysical studies: from vesicles to cells
  64. Monitoring antibacterial permeabilization in real time using time-resolved flow cytometry
  65. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
  66. Integrative Human Biochemistry
  67. Introduction to Metabolism
  68. The Regulation of Metabolisms
  69. Regulation and Integration of Metabolism During Physical Activity
  70. The Families of Biological Molecules
  71. The Chemistry and Physics of Life
  72. Catabolism of the Major Biomolecules
  73. Introduction: Life Is Made of Molecules!
  74. Energy Conservation in Metabolism: The Mechanisms of ATP Synthesis
  75. Regulation and Integration of Metabolism During Hypoglycemia
  76. Metabolic Responses to Hyperglycemia: Regulation and Integration of Metabolism in the Absorptive State
  77. Correlation between membrane translocation and analgesic efficacy in kyotorphin derivatives
  78. Enhanced HIV Fusion Inhibitors Efficacy Requires Membrane Affinity and Exposure of the Pocket Binding Domain of C34 Derivatives
  79. Receptors and routes of dengue virus entry into the host cells
  80. The interaction of antibodies with lipid membranes unraveled by fluorescence methodologies
  81. Understanding Dengue Virus Capsid Protein Disordered N-Terminus and pep14-23-Based Inhibition
  82. The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer’s Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers
  83. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria
  84. Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors
  85. Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies
  86. The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
  87. Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure
  88. Dengue virus capsid protein interacts specifically with very low-density lipoproteins
  89. Dengue Virus Capsid Protein Delivers Nucleic Acids Intracellularly
  90. Dengue Virus Capsid Protein Interacts Specifically with Very Low-Density Lipoproteins
  91. New Broad-Spectrum Viral Fusion Inhibitors Act by Deleterious Effect on the Viral Membrane through the Production Singlet Oxygen Molecules
  92. Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein
  93. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action
  94. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures
  95. The Antimicrobial Activity of Sub3 is Dependent on Membrane Binding and Cell-Penetrating Ability
  96. N-Terminal AH2 segment of protein NS4B from hepatitis C virus. Binding to and interaction with model biomembranes
  97. Decoding distinct membrane interactions of HIV-1 fusion inhibitors using a combined atomic force and fluorescence microscopy approach
  98. Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid
  99. A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
  100. Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
  101. Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs
  102. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria
  103. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems
  104. The Dengue Virus Capsid Protein Inhibitor Peptide Pep14-23 becomes Alpha-Helical upon Binding to Negative Lipids
  105. Dengue Virus Capsid Protein Binding to Lipid Droplets and its Inhibition. towards a New Drug Target
  106. From antimicrobial to anticancer peptides. A review
  107. Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer’s Disease Patients: Potential Diagnostic and Pharmacological Implications
  108. The application of biophysical techniques to study antimicrobial peptides
  109. Arginine-rich self-assembling peptides as potent antibacterial gels
  110. Antimicrobial Peptide rBPI21: A Translational Overview from Bench to Clinical Studies
  111. Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
  112. Anticancer Peptide SVS-1: Efficacy Precedes Membrane Neutralization
  113. Phosphatidylethanolamine Binding Is a Conserved Feature of Cyclotide-Membrane Interactions
  114. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif
  115. A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System
  116. Peptide Drug Discovery and Development: Translational Research in Academia and Industry. Edited by Miguel Castanho and Nuno C. Santos.
  117. Antimicrobial properties of analgesic kyotorphin peptides unraveled through atomic force microscopy
  118. Electron/proton coupling in biological energy transduction
  119. Short Stories - on Antimicrobial Peptides that are Too Short to Span the Membrane
  120. Biomedical applications of dipeptides and tripeptides
  121. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by brownian dynamics simulations on a coarse-grained model
  122. The Researching, Teaching, and Learning Triangle
  123. The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria
  124. Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Synergistically Potentiates Peptide-Membrane Interaction
  125. Relating Molecular-Level Events with Bacterial Killing by Antimicrobial Peptides
  126. Translocating the blood-brain barrier using electrostatics
  127. Biophysical characterization of polymyxin b interaction with LPS aggregates and membrane model systems
  128. The Application of Biophysical Techniques to Study Antimicrobial Peptides
  129. Decoding Distinct Membrane Interactions of HIV-1 Inhibitors Enfuvirtide and T-1249 using Atomic Force Microscopy Combined with Fluorescence Methodologies
  130. Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides
  131. Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is Potassium Ion Dependent and Is Mediated by LD Surface Proteins
  132. Peptide Drug Discovery and Development
  133. Chemical Conjugation of the Neuropeptide Kyotorphin and Ibuprofen Enhances Brain Targeting and Analgesia
  134. Inhibition of nociceptive responses after systemic administration of amidated kyotorphin
  135. Decoding the Membrane Activity of the Cyclotide Kalata B1
  136. Characterization of the Interaction of the Dengue Virus Capsid Protein with Lipid Droplets
  137. rBPI21 Causes (HEMI)Fusion and Leakage of Membranes and Promotes Massive Lipopolysaccharide Aggregation
  138. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes
  139. Using zeta-potential measurements to quantify peptide partition to lipid membranes
  140. Cationic liposomes are possible drug-delivery systems for HIV fusion inhibitor sifuvirtide
  141. The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide
  142. Quantitative assessment of peptide–lipid interactions.
  143. Drug–lipid interaction evaluation: why a 19th century solution?
  144. Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
  145. Escherichia coliCell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR
  146. Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes
  147. Is PrP(106-126) Fragment Involved in the Membrane Activity of the Prion Protein?
  148. HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
  149. In Vitro Blood-Brain Barrier Models – Latest Advances and Therapeutic Applications in a Chronological Perspective
  150. Membrane-Active Peptides: Methods and Results on Structure and Function
  151. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: A kinetic study followed by surface plasmon resonance
  152. Unraveling the Molecular Basis of the Selectivity of the HIV-1 Fusion Inhibitor Sifuvirtide Towards Phosphatidylcholine-Rich Rigid Membranes
  153. rBPI21 Promotes Lipopolysaccharide Aggregation and Exerts Its Antimicrobial Effects by (Hemi)fusion of PG-Containing Membranes
  154. Interaction of the Dengue Virus Fusion Peptide with Membranes Assessed by NMR: The Essential Role of the Envelope Protein Trp101 for Membrane Fusion
  155. The Toxicity of Prion Protein Fragment PrP(106−126) is Not Mediated by Membrane Permeabilization as Shown by a M112W Substitution
  156. Interactions of HIV-1 Antibodies 2F5 and 4E10 with a gp41 Epitope Prebound to Host and Viral Membrane Model Systems
  157. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
  158. Synergistic Effects of the Membrane Actions of Cecropin-Melittin Antimicrobial Hybrid Peptide BP100
  159. Human Erythrocytes And Mononuclear Leukocytes Are Capable Of Concentrating HIV-1 Fusion Inhibitor Peptides In Their Membranes
  160. Fold-Unfold Transitions in the Selectivity and Mechanism of Action of the N-Terminal Fragment of the Bactericidal/Permeability-Increasing Protein (rBPI21)
  161. PrP(106-126) Does Not Interact with Membranes under Physiological Conditions
  162. Sifuvirtide Screens Rigid Membrane Surfaces. Establishment of a Correlation between Efficacy and Membrane Domain Selectivity among HIV Fusion Inhibitor Peptides
  163. Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2
  164. Translocation or membrane disintegration? Implication of peptide–membrane interactions in pep-1 activity
  165. Enfuvirtide effects on human erythrocytes and lymphocytes functional properties
  166. Biophysics meets membrane-active peptides
  167. Interaction between dengue virus fusion peptide and lipid bilayers depends on peptide clustering
  168. What can light scattering spectroscopy do for membrane-active peptide studies?
  169. Molecular interaction studies of peptides using steady-state fluorescence intensity. Static (de)quenching revisited
  170. The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers
  171. Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation
  172. Shiga toxin B-subunit sequential binding to its natural receptor in lipid membranes
  173. How to address CPP and AMP translocation? Methods to detect and quantify peptide internalizationin vitroandin vivo(Review)
  174. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1
  175. Cell-penetrating peptides and antimicrobial peptides: how different are they?
  176. The membranes’ role in the HIV-1 neutralizing monoclonal antibody 2F5 mode of action needs re-evaluation
  177. Chiral Recognition ofD-Kyotorphin by Lipidic Membranes: Relevance Toward Improved Analgesic Efficiency
  178. Omiganan Pentahydrochloride in the Front Line of Clinical Applications of Antimicrobial Peptides
  179. Conformational and Orientational Guidance of the Analgesic Dipeptide Kyotorphin Induced by Lipidic Membranes:  Putative Correlation toward Receptor Docking
  180. An Insight on the Leading HIV Entry Inhibitors
  181. Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions
  182. Miguel A.R.B. Castanho
  183. Lipid membrane-induced optimization for ligand–receptor docking: recent tools and insights for the “membrane catalysis” model
  184. Translocation of β-Galactosidase Mediated by the Cell-Penetrating Peptide Pep-1 into Lipid Vesicles and Human HeLa Cells Is Driven by Membrane Electrostatic Potential†
  185. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides
  186. Overview of Common Spectroscopic Methods to Determine the Orientation/Alignment of Membrane Probes and Drugs in Lipidic Bilayers
  187. Environmental factors that enhance the action of the cell penetrating peptide pep-1
  188. Developing students' awareness of public understanding of science: A matter of survival?
  189. Lipidic Membranes Are Potential “Catalysts” in the Ligand Activity of the Multifunctional Pentapeptide Neokyotorphin
  190. Cholesterol modulates maculosin's orientation in model systems of biological membranes
  191. HIV Fusion Inhibitor Peptide T-1249 Is Able To Insert or Adsorb to Lipidic Bilayers. Putative Correlation with Improved Efficiency
  192. Consequences of Nonlytic Membrane Perturbation to the Translocation of the Cell Penetrating Peptide Pep-1 in Lipidic Vesicles†
  193. Does Aliphatic Chain Length Influence Carbocyanines' Orientation in Supported Lipid Multilayers?
  194. Filipin Orientation Revealed by Linear Dichroism. Implication for a Model of Action
  195. What do college life sciences students need to know about knowledge management?
  196. An overview of the biophysical applications of atomic force microscopy
  197. Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level
  198. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods
  199. Evaluation of Lipopolysaccharide Aggregation by Light Scattering Spectroscopy
  200. Lipossomas: a bala mágica acertou?
  201. Teaching Molecular Applications of the Particle-in-a-Ring Model Using Azulene
  202. Brownian dynamics simulation of the unsaturated lipidic molecules oleic and docosahexaenoic acid confined in a cellular membrane
  203. Joint determination by Brownian dynamics and fluorescence quenching of the in-depth location profile of biomolecules in membranes
  204. Revealing the Orientation of Nystatin and Amphotericin B in Lipidic Multilayers by UV−Vis Linear Dichroism
  205. Dealing with the challenges of teaching molecular biophysics to biochemistry majors through an heuristics-based approach
  206. Crude tall-oil sodium salts micellization in aqueous solutions studied by static and dynamic light scattering
  207. A photophysical study of the polyene antibiotic filipin
  208. Conference Report
  209. Meeting Report — Biochemical Education at the University Level, Lisbon, Portugal, October 30−31, 1999
  210. Conformation and dynamic properties of a saturated hydrocarbon chain confined in a model membrane: a Brownian dynamics simulation
  211. Overcoming Angular Dependency When Teaching Light Scattering Using a Spectrofluorometer: The Molecular Weight of Latex Beads
  212. The pentaene macrolide antibiotic filipin prefers more rigid DPPC bilayers: a fluorescence pressure dependence study
  213. Simulation of the distribution and diffusion of a rigid amphipathic particle embedded in a model membrane
  214. Reconstitution of Phospholipid Bilayer by an Atomic Force Microscope Tip
  215. Filipin-Induced Lesions in Planar Phospholipid Bilayers Imaged by Atomic Force Microscopy
  216. Fluorescence quenching data interpretation in biological systems
  217. Continuous particle size distribution analysis with dynamic light scattering
  218. Interaction of the Major Epitope Region of HIV Protein gp41 with Membrane Model Systems. A Fluorescence Spectroscopy Study†
  219. Separating the turbidity spectra of vesicles from the absorption spectra of membrane probes and other chromophores
  220. Structural characterization of organized systems of polysaccharides and phospholipids by light scattering spectroscopy and electron microscopy
  221. Structural characterization (shape and dimensions) and stability of polysaccharide/lipid nanoparticles
  222. Snatos, Nuno C., and Miguel A. R. B. Castanho. 1996. Biophys. J. 71:1641–1650
  223. The Shape, Dimension and Organisation of Maltodextrins Gel Fragments with and without Associated Phospholipids
  224. Teaching light scattering spectroscopy: the dimension and shape of tobacco mosaic virus
  225. The transverse location of the fluorescent probe trans-parinaric acid in lipid bilayers
  226. Filipin fluorescence quenching by spin-labeled probes: studies in aqueous solution and in a membrane model system
  227. Filipin and its interaction with cholesterol in aqueous media studied using static and dynamic light scattering
  228. Fluorescence study of a derivatized diacylglycerol incorporated in model membranes
  229. Rod-like cholesterol micelles in aqueous solution studied using polarized and depolarized dynamic light scattering
  230. Fluorescence study of the macrolide pentaene antibiotic filipin in aqueous solution and in a model system of membranes